(1)
Understanding Triple Negative Breast Cancer: A Review on Molecular Signaling Pathways. Int. J. Pharm. Sci. Drug Res. 2022, 14 (2), 290-299. https://doi.org/10.25004/IJPSDR.2022.140220.